Intrepid Capital Management Inc. Has $289,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Intrepid Capital Management Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 572 shares of the healthcare conglomerate’s stock after buying an additional 44 shares during the period. Intrepid Capital Management Inc.’s holdings in UnitedHealth Group were worth $289,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Howard Capital Management Group LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $341,000. Principal Financial Group Inc. lifted its position in UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Bamco Inc. NY increased its holdings in UnitedHealth Group by 2.0% during the 3rd quarter. Bamco Inc. NY now owns 56,890 shares of the healthcare conglomerate’s stock worth $33,262,000 after purchasing an additional 1,089 shares in the last quarter. Concentric Capital Strategies LP lifted its holdings in shares of UnitedHealth Group by 40.2% in the third quarter. Concentric Capital Strategies LP now owns 3,843 shares of the healthcare conglomerate’s stock valued at $2,247,000 after purchasing an additional 1,101 shares in the last quarter. Finally, Cinctive Capital Management LP acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $3,619,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on UNH. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Performance

UNH opened at $522.97 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $478.37 billion, a PE ratio of 33.74, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The business has a fifty day simple moving average of $509.06 and a 200 day simple moving average of $542.96.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the firm earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.61%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.